Ulinastatin inhibits apoptosis induced by serum deprivation in mesenchymal stem cells
- 11 January 2019
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 19 (3), 2397-2406
- https://doi.org/10.3892/mmr.2019.9847
Abstract
Mesenchymal stem cells (MSCs) have exhibited great potential in the therapy of cardiovascular disease. However, the application of MSCs is hampered by apoptosis, which reduces the number of cells in the host cardiac microenvironment. Ulinastatin (UTI), a broad-spectrum protease inhibitor that can be purified from human urine, has attracted attention for its protective effects through its immunomodulatory and anti-inflammatory properties. The present study aimed to evaluate the effects of UTI on serum deprivation-induced apoptosis of MSCs and investigate its molecular mechanisms. Cell viability was determined by the MTT assay. Apoptosis was assessed by flow cytometric analysis with Annexin V/propidium iodide staining. The protein levels of cleaved caspase-3, B-cell lymphoma-2 (Bcl-2) family proteins, total-Akt and phospho-Akt were evaluated by western blot. The results of the present study demonstrated that UTI exhibited a protective effect in serum deprived MSCs, as indicated by increased cell viability, and a reduction in the rate of apoptosis and caspase-3 activation. In addition, treatment with UTI significantly decreased the expression levels of Bcl-2, Bcl-extra large and Bcl-associated X protein. Furthermore, activation of the Akt signaling pathway was involved in the UTI-induced anti-apoptotic effects. The present findings indicated that UTI is able to promote the survival of MSCs under serum deprivation conditions. The present study may be helpful in improving the therapeutic efficacy of MSC transplantation used to cure chronic ischemic heart disease.Keywords
This publication has 27 references indexed in Scilit:
- 10 Years of Intracoronary and Intramyocardial Bone Marrow Stem Cell Therapy of the Heart: From the Methodological Origin to Clinical PracticeJournal of Invasive Cardiology, 2011
- mTOR as a multifunctional therapeutic target in HIV infectionDrug Discovery Today, 2011
- Induction of ER stress in response to oxygen-glucose deprivation of cortical cultures involves the activation of the PERK and IRE-1 pathways and of caspase-12Cell Death & Disease, 2011
- Potential use of rapamycin in HIV infectionBritish Journal of Clinical Pharmacology, 2010
- Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disordersExpert Opinion on Investigational Drugs, 2010
- Real-Time Redox Measurements during Endoplasmic Reticulum Stress Reveal Interlinked Protein Folding FunctionsCell, 2008
- Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: A quantitative assessmentLife Sciences, 2008
- Current Status and Future Prospects for Cell Transplantation to Prevent Congestive Heart FailureSeminars in Thoracic and Cardiovascular Surgery, 2008
- The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction modelCardiovascular Research, 2006
- Improved Graft Mesenchymal Stem Cell Survival in Ischemic Heart With a Hypoxia-Regulated Heme Oxygenase-1 VectorJournal of Invasive Cardiology, 2005